SEC Form 4 · accession 0001178913-26-004392
MediWound Ltd. · MDWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel Rubinstein
Director
Period of report
Sep 1, 2026
Accepted (ET)
Sep 2, 2026 · 4:02 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001593984
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Sep 1, 2026 | S | 525 | $12.72 | D | 0 | I | By spouse |
| Ordinary Shares | Sep 1, 2026 | P | 525 | $12.62 | A | 525 | I | By spouse |
| Ordinary SharesF2 | holding | — | — | — | 2,993 | D | ||
| Ordinary sharesF1,F2 | holding | — | — | — | 750 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy ordinary shares)F2 | $9.64 | holding | — | — | — | Aug 15, 2024 | Aug 15, 2033 | Ordinary Shares | 7,200 | 7,200 | D |
| Stock Option (right to buy ordinary shares)F2 | $12.729 | holding | — | — | — | Feb 26, 2025 | Feb 26, 2034 | Ordinary Shares | 7,542 | 7,542 | D |
| Stock Option (right to buy ordinary shares)F2 | $18.54 | holding | — | — | — | Feb 11, 2026 | Feb 11, 2035 | Ordinary Shares | 5,600 | 5,600 | D |
| Stock Option (right to buy ordinary shares)F2,F3 | $17.60 | holding | — | — | — | — | Mar 4, 2036 | Ordinary Shares | 6,250 | 6,250 | D |
Explanation of responses
- F1The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
- F2There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F3The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
Remarks
The Issuer is a foreign private issuer as defined under Rule 3b-4 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). In accordance with Rule 3a12-3(b) under the Exchange Act, the Reporting Person is exempt from the short-swing profit recovery provisions of Section 16(b) of the Exchange Act.